siRNA treatment lowers triglycerides in people with rare health condition

.RESEARCH FEATURE.19 September 2024.

Plozasiran lessened triglyceride amounts through 80% and also lowered the threat of pancreatitis in individuals with chronic chylomicronemia, with or without a hereditary diagnosis.